Physician profile
Rachel Smith
NPI 1881065845
$1,791.58
in general payments reported to CMS, 2019-2025
13 companies · $14.35 in 2025
The $14.35 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $307 · 2022: $235 · 2023: $53.37 · 2024: $1,182 · 2025: $14.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,003 · Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,002.87 |
| Food and Beverage | $246.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,182.09 | 2024 | Iovera |
| Endo Pharmaceuticals INC. | $243.02 | 2021-2023 | Xiaflex |
| Pacira Therapeutics, INC. | $128.11 | 2021 | |
| Amgen INC. | $46.15 | 2022-2023 | Prolia, Evenity |
| Janssen Biotech, INC. | $41.58 | 2021 | |
| Vertos Medical, INC. | $27.56 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.18 | 2021 | |
| Baxter Healthcare | $22.12 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $21.84 | 2022 | |
| Radius Health, INC. | $18.03 | 2021 | |
| Curonix LLC | $14.35 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Acelrx Pharmaceuticals, INC. | $14.18 | 2021 | |
| Heron Therapeutics, INC. | $9.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.